Table 2:
Mixed model analysis comparing the humoral immune response elicited in the plasma and airways by ID BCG versus IV BCG at different time points.
| Niche | Immunoglobulin | BCG ID vs. BCG IV | P-value | Mean Difference: BCG ID - BCG IV (95% CI) | |
|---|---|---|---|---|---|
| Plasma | IgG WCL | PreBCG | 0.3107 | ns | |
| 4 weeks post BCG | 0.0421 | * | −1.095 (−2.140 to 0.04976) | ||
| 18 weeks post BCG | 0.04 | * | −0.4427 (−0.8598 to −0.0255) | ||
|
| |||||
| IgM WCL | PreBCG | 0.432 | ns | ||
| 4 weeks post BCG | 0.3434 | ns | |||
| 18 weeks post BCG | 0.1954 | ns | |||
|
| |||||
| IgG LAM | PreBCG | 0.5487 | ns | ||
| 4 weeks post BCG | 0.5161 | ns | |||
| 18 weeks post BCG | 0.8804 | ns | |||
|
| |||||
| IgM LAM | PreBCG | 0.3632 | ns | ||
| 4 weeks post BCG | 0.0039 | ** | −0.8388 (−1.227 to −0.4506) | ||
| 18 weeks post BCG | 0.432 | ns | |||
|
| |||||
| BAL (airway) | IgG WCL | PreBCG | 0.7060 | ns | |
| 4 weeks post BCG | 0.0016 | ** | −1.305 (−2.141 to −0.4682) | ||
| 18 weeks post BCG | 0.1002 | ns | |||
|
| |||||
| IgM WCL | PreBCG | >0.9999 | ns | ||
| 4 weeks post BCG | 0.3160 | ns | |||
| 18 weeks post BCG | 0.4222 | ns | |||
|
| |||||
| IgG LAM | PreBCG | 0.0878 | # | −1.180 (−2.466 to 0.1059) | |
| 4 weeks post BCG | 0.006 | ** | −1.841 (−3.099 to −0.5823) | ||
| 18 weeks post BCG | 0.0222 | * | −1.752 (−3.229 to −0.2744) | ||
|
| |||||
| IgM LAM | PreBCG | 0.0727 | # | −0.8621 (−1.810 to 0.08572) | |
| 4 weeks post BCG | 0.0975 | # | 0.7920 (−1.7840 to 0.1558) | ||
| 18 weeks post BCG | 0.0240 | * | −1.300 (−2.413 to −0.1864) | ||
ID and IV BCG were compared at each time point for each cell type. Fisher’s LSD test p-values reported.
For p-values < 0.10, the mean difference of ID BCG - IV BCG is shown with 95% confidence interval.
The summary of p-value is presented;
0.05 < p < 0.10,
p < 0.05,
p < 0.01 and
p < 0.001.
WCL: H37Rv whole cell lysate, LAM: Lipoarabinomannan.